Disclosures for "T-cell Therapy for Progressive Multifocal Leukoencephalopathy"
-
Dr. Gupta has nothing to disclose.
-
Dr. Martinov has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Martinov has stock in Bristol Myers Squibb. Dr. Martinov has received research support from Cancer Research Institute. Dr. Martinov has received intellectual property interests from a discovery or technology relating to health care.
-
Mrs. Thelen has received personal compensation for serving as an employee of Bristol-Myers Squibb. Mrs. Thelen has received intellectual property interests from a discovery or technology relating to health care.
-
Miss Sunahara has stock in Invitae.
-
The institution of Miss Schanzer has received research support from Weill Neurohub.
-
Dr. Urnov has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Tune Therapeutics. Dr. Urnov has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Urnov has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cimeio Therapeutics. Dr. Urnov has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex Pharmaceuticals. The institution of Dr. Urnov has received research support from Weill Neurohub.
-
Dr. Marson has received personal compensation for serving as an employee of Gladstone. Dr. Marson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Marson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Spotlight. Dr. Marson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 23andMe. Dr. Marson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Marson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Marson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Marson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spotlight. Dr. Marson has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArsenalBio. Dr. Marson has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NewLimit. Dr. Marson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Survey Genomics. Dr. Marson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tenaya Therapeutics. Dr. Marson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lightcast Discovery Ltd. Dr. Marson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for 23andMe. Dr. Marson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ArsenalBio. Dr. Marson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Spotlight. Dr. Marson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Survey Genomics. Dr. Marson has stock in Survey Genomics. Dr. Marson has stock in ArsenalBio. Dr. Marson has stock in Spotlight. Dr. Marson has stock in NewLimit. Dr. Marson has stock in Tenaya Therapeutics. Dr. Marson has received research support from available upon request. Dr. Marson has received intellectual property interests from a discovery or technology relating to health care. Dr. Marson has received intellectual property interests from a discovery or technology relating to health care. Dr. Marson has received personal compensation in the range of $500-$4,999 for serving as a Fellowship Award Committee Member with Damon Runyon. Dr. Marson has received personal compensation in the range of $0-$499 for serving as a Dissertation Defense Committee Member with Gerstner Sloan Kettering Graduate School.
-
Dr. Shy has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Affini-T Therapeutics. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Elpiscience. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunoscape. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapt Therapeutics. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nextech. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AACR. Dr. Greenberg has stock in Affini-T. Dr. Greenberg has stock in Elpiscience. Dr. Greenberg has stock in Immunoscape. Dr. Greenberg has stock in Rapt Therapeutics. Dr. Greenberg has stock in Earli. Dr. Greenberg has stock in Nextech. Dr. Greenberg has stock in Catalio. Dr. Greenberg has stock in Metagenomi. The institution of Dr. Greenberg has received research support from Affini-T Therapeutics. The institution of Dr. Greenberg has received research support from Lonza. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from UCSF Weill Institute for Neurosciences. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.